Product Program year 2025 Source: CMS Open Payments

enVista Aspire IOL

Device Ophthalmology

PDI 10757770608796

Open in the dashboard

General payments

$368,948

1,261 payments

Research payments

$0

0 payments

Through program year 2025, $368,948 in general payments and $0 in research payments were reported against enVista Aspire IOL (Ophthalmology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $24,960 287
2024 General $343,988 974

Breakdown

Who paid General payments · program years 2024–2025
  1. Bausch & Lomb Americas Inc. $368,948 1,261 payments
Top recipients General payments · program year 2025
  1. Rajen Desai Ophthalmology · Freehold, NJ $6,830 27% · 4 payments
  2. Jai Parekh Ophthalmology · Woodland Park, NJ $2,712 11% · 4 payments
  3. Alyson Yashar Ophthalmology · Woodcliff Lake, NJ $278 1% · 3 payments
  4. Eric Gershenbaum Ophthalmology · Freehold, NJ $262 1% · 2 payments
  5. Revathi Naadimuthu Ophthalmology · Freehold, NJ $262 1% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Ophthalmology $17,838 74% · 124 practitioners
  2. Optometrist $4,999 21% · 53 practitioners
  3. Retina Specialist Ophthalmology $407 2% · 5 practitioners
  4. Glaucoma Specialist Ophthalmology $197 <1% · 5 practitioners
  5. Internal Medicine $145 <1% · 1 practitioner

The top 5 of 13 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New Jersey $12,590 50% · 28 recipients
  2. North Carolina $3,783 15% · 35 recipients
  3. Pennsylvania $2,417 10% · 33 recipients
  4. New York $1,470 6% · 21 recipients
  5. South Carolina $1,059 4% · 11 recipients

The top 5 of 26 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,261 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record